Diamyd Medical AB (publ) reported earnings results for the fourth quarter and full year ended August 31, 2023. For the fourth quarter, the company reported sales was SEK 0.074 million compared to SEK 0.059 million a year ago. Revenue was SEK 11.17 million compared to SEK 1.16 million a year ago. Net loss was SEK 21.65 million compared to SEK 36.73 million a year ago. Basic loss per share from continuing operations was SEK 0.3 compared to SEK 0.5 a year ago.
For the full year, sales was SEK 0.546 million compared to SEK 0.454 million a year ago. Revenue was SEK 19.61 million compared to SEK 2.58 million a year ago. Net loss was SEK 100.21 million compared to SEK 103.52 million a year ago. Basic loss per share from continuing operations was SEK 1.3 compared to SEK 1.4 a year ago.